Yifeng Pharmacy (603939) — Cash Flow-to-Debt Ratio
Yifeng Pharmacy (603939) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥641.93 Million could theoretically repay 0% of its total liabilities (CN¥14.41 Billion) in one year. Explore 603939 long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yifeng Pharmacy Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Yifeng Pharmacy across 14 annual periods. Also explore Yifeng Pharmacy total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Yifeng Pharmacy (2011–2024)
Year-by-year debt coverage analysis for Yifeng Pharmacy. For market capitalisation and broader financial context, see market value of Yifeng Pharmacy.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | CN¥4.22 Billion | CN¥16.58 Billion | ▼ -25.3% |
| 2023 | 0.34x | CN¥4.66 Billion | CN¥13.69 Billion | ▲ +3.6% |
| 2022 | 0.33x | CN¥3.92 Billion | CN¥11.92 Billion | ▲ +40.6% |
| 2021 | 0.23x | CN¥2.15 Billion | CN¥9.19 Billion | ▲ +25.6% |
| 2020 | 0.19x | CN¥1.34 Billion | CN¥7.17 Billion | ▼ -13.6% |
| 2019 | 0.22x | CN¥963.23 Million | CN¥4.47 Billion | ▲ +56.2% |
| 2018 | 0.14x | CN¥510.71 Million | CN¥3.70 Billion | ▼ -30.2% |
| 2017 | 0.20x | CN¥317.20 Million | CN¥1.60 Billion | ▲ +76.2% |
| 2016 | 0.11x | CN¥139.94 Million | CN¥1.25 Billion | ▼ -37.1% |
| 2015 | 0.18x | CN¥181.52 Million | CN¥1.02 Billion | ▼ -44.9% |
| 2014 | 0.32x | CN¥212.35 Million | CN¥655.19 Million | ▲ +8.4% |
| 2013 | 0.30x | CN¥156.71 Million | CN¥524.21 Million | ▲ +55.4% |
| 2012 | 0.19x | CN¥80.73 Million | CN¥419.63 Million | ▼ -23.8% |
| 2011 | 0.25x | CN¥122.99 Million | CN¥487.12 Million | — |